Name:
Oxaliplatin (Related Reference)
Molecular Formula:
C8H12N2O4Pt
CAS Registry Number:
61825-94-3;63121-00-6
Synonyms:
(sp-4-2)-((1r,2r)-1,2-cyclohexanediamine-n,n')(ethanedioato(2-)-O,O']platinum; latin; xalatoplatinum; ι-OHP; RP-54780; NSC-266046; Elocatin; trans-L-Diaminocyclohexane oxalatoplatinum; Oxalato(trans-(-)-1,2-cyclohexanediamine)platinum(II)
*The following content is generated by AI and is for reference only.
Overview
Oxaliplatin is a third-generation platinum-based chemotherapeutic agent synthesized via coordination reaction. Its molecular formula is C8H14N2O4Pt with CAS No. 61825-94-3.
Application
- Oncology Manufacturing: Primary treatment for metastatic colorectal cancer.
- Combination Therapy: Used in FOLFOX regimens with 5-FU and leucovorin.
- R&D Supply: Bulk API provision for clinical trials and pharmaceutical formulation.
Precautions
Strictly avoid exposure to light and store at controlled room temperature. Handle as a cytotoxic substance requiring PPE; contraindicated in patients with severe hypersensitivity to platinum compounds.